Human News

ATCO Company is honored to thank our eminent professors of diabetes and cardiology for their participation in the annual scientific meeting in Istanbul to discuss the latest updates in CVM field regarding SGLT2 inhibitors

ATCO is exerting efforts to raise Patient awareness in Egypt. One of its activities is to participate in major health days as per Marketing directions. ATCO participated in celebrating “The World Diabetes Day” under the supervision of Dr Salwa Sadek (Head of Endocrinology Department of Demerdash Hospital) and Dr Jehan ( Ain shams university vice president)

Atco pharma as part of its role in continuous medical education honorably was held meet the expert scientific event in cardiovascular and vascular surgery discussing the updates in management of AF and DVT and the recent guidelines recommendations

Atco Pharma proudly hosted the highly anticipated Tovoniza Launch Event on June 2nd,2023, at the exquisite Triumph Luxury Hotel. The attendance exceeds 450 esteemed doctors, marked a significant milestone in the pharmaceutical industry.

Atco Pharma honored to launch Atcogliflozin as Empagliflozin; The new approach for treatment of Diabetes, Heart Failure and CKD (Choric Kidney Disease)

ATCOPharma Company is honored to thank our eminent Neurology & OrthopedicSurgery professors for participating in the ATCO scientific event held inSteigenberger Ras EL Bar to Discuss the latest updates in NP management.